Home
ACIU
ACIU News

Latest AC Immune SA (ACIU) News on March 29, 2025

AC Immune Announces Upcoming Presentations and Industry Symposium on Active Immunotherapies at AD/PD™ 2025

GlobeNewswire

4 days ago

AC Immune Announces Upcoming Presentations and Industry Symposium on Active Immunotherapies at AD/PD™ 2025

ACIU Stock Crashes 18.3% in a Month: Buy, Sell or Hold?

Zacks

5 days ago

ACIU Stock Crashes 18.3% in a Month: Buy, Sell or Hold?

AC Immune (NASDAQ:ACIU) investors are sitting on a loss of 52% if they invested five years ago

Simply Wall St.

13 days ago

AC Immune (NASDAQ:ACIU) investors are sitting on a loss of 52% if they invested five years ago

AC Immune Reports Full Year 2024 Financial Results and Provides a Corporate Update

GlobeNewswire

16 days ago

AC Immune Reports Full Year 2024 Financial Results and Provides a Corporate Update

AC Immune (ACIU) Upgraded to Strong Buy: Here's What You Should Know

Zacks

24 days ago

AC Immune (ACIU) Upgraded to Strong Buy: Here's What You Should Know

AC Immune to Participate in Upcoming Investor Conferences

GlobeNewswire

25 days ago

AC Immune to Participate in Upcoming Investor Conferences

Down -9.7% in 4 Weeks, Here's Why You Should You Buy the Dip in AC Immune (ACIU)

Zacks

a month ago

Down -9.7% in 4 Weeks, Here's Why You Should You Buy the Dip in AC Immune (ACIU)

3 US Penny Stocks With Market Caps Over $100M To Consider

Simply Wall St.

2 months ago

3 US Penny Stocks With Market Caps Over $100M To Consider

US Penny Stocks Spotlight: AC Immune And Two Others To Consider

Simply Wall St.

3 months ago

US Penny Stocks Spotlight: AC Immune And Two Others To Consider

High Growth Tech Stocks in the United States

Simply Wall St.

3 months ago

High Growth Tech Stocks in the United States

AC Immune announces interim safety, tolerability data from ABATE Phase 1b/2

TipRanks

4 months ago

AC Immune announces interim safety, tolerability data from ABATE Phase 1b/2

AC Immune Reports Interim Safety Data from Phase 1b/2 ABATE Trial of ACI-24.060 in Down syndrome

GlobeNewswire

4 months ago

AC Immune Reports Interim Safety Data from Phase 1b/2 ABATE Trial of ACI-24.060 in Down syndrome

AC Immune’s stock jumps after Parkinson’s therapy shows signs of benefit

Pharmaceutical Technology

4 months ago

AC Immune’s stock jumps after Parkinson’s therapy shows signs of benefit

AC Immune reports interim results from Phase 2 trial of ACI-7104.056

TipRanks

4 months ago

AC Immune reports interim results from Phase 2 trial of ACI-7104.056

MT Newswires

4 months ago

Sector Update: Health Care Stocks Lower Thursday Afternoon

MT Newswires

4 months ago

AC Immune Shares Gain Following Positive Clinical Results of Potential Parkinson's Treatment

AC Immune Reports Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease

GlobeNewswire

4 months ago

AC Immune Reports Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease

AC Immune to Present at the Jefferies 2024 London Healthcare Conference

GlobeNewswire

5 months ago

AC Immune to Present at the Jefferies 2024 London Healthcare Conference

AC Immune SA Beat Analyst Profit Forecasts, And Analysts Have New Estimates

Simply Wall St.

5 months ago

AC Immune SA Beat Analyst Profit Forecasts, And Analysts Have New Estimates

Associated Press Finance

5 months ago

AC Immune: Q3 Earnings Snapshot

AC Immune Reports Third Quarter 2024 Financial Results and Provides a Corporate Update

GlobeNewswire

5 months ago

AC Immune Reports Third Quarter 2024 Financial Results and Provides a Corporate Update

AC Immune SA (NASDAQ:ACIU) stock most popular amongst individual investors who own 32%, while private equity firms hold 29%

Simply Wall St.

5 months ago

AC Immune SA (NASDAQ:ACIU) stock most popular amongst individual investors who own 32%, while private equity firms hold 29%

What To Expect From AC Immune SA (ACIU) Q3 2024 Earnings

GuruFocus.com

5 months ago

What To Expect From AC Immune SA (ACIU) Q3 2024 Earnings

MT Newswires

6 months ago

Sector Update: Health Care Stocks Steady Premarket Tuesday

MT Newswires

6 months ago

Sector Update: Health Care

MT Newswires

6 months ago

AC Immune Expects $29 Million Milestone Payment From Janssen

AC Immune Receives Second Milestone Payment Following Progress in Phase 2b ReTain Trial of ACI-35.030 in Preclinical Alzheimer’s Disease

GlobeNewswire

6 months ago

AC Immune Receives Second Milestone Payment Following Progress in Phase 2b ReTain Trial of ACI-35.030 in Preclinical Alzheimer’s Disease

FDA grants fast track designation to Life Molecular Imaging’s tau PET diagnostic

Medical Device Network

7 months ago

FDA grants fast track designation to Life Molecular Imaging’s tau PET diagnostic

MT Newswires

7 months ago

AC Immune's Partner Life Molecular Gets FDA Fast Track Designation for PET Imaging Agent

AC Immune’s PI-2620 Tau-PET Diagnostic in Phase 3 Receives Fast Track Designation in Three Neurodegenerative Conditions

GlobeNewswire

7 months ago

AC Immune’s PI-2620 Tau-PET Diagnostic in Phase 3 Receives Fast Track Designation in Three Neurodegenerative Conditions

The past three years for AC Immune (NASDAQ:ACIU) investors has not been profitable

Simply Wall St.

7 months ago

The past three years for AC Immune (NASDAQ:ACIU) investors has not been profitable

AC Immune (ACIU) Reports Q2 Loss, Lags Revenue Estimates

Zacks

8 months ago

AC Immune (ACIU) Reports Q2 Loss, Lags Revenue Estimates

Associated Press Finance

8 months ago

AC Immune: Q2 Earnings Snapshot

AC Immune Reports Second Quarter 2024 Financial Results and Provides a Corporate Update

GlobeNewswire

8 months ago

AC Immune Reports Second Quarter 2024 Financial Results and Provides a Corporate Update

AC Immune Unveils Novel Therapeutic Antibody Drug Conjugate (ADC) Technology for Improved Efficacy in Neurodegenerative Diseases at AAIC 2024

GlobeNewswire

8 months ago

AC Immune Unveils Novel Therapeutic Antibody Drug Conjugate (ADC) Technology for Improved Efficacy in Neurodegenerative Diseases at AAIC 2024

MT Newswires

8 months ago

Sector Update: Health Care Stocks Decline Late Afternoon

MT Newswires

8 months ago

Sector Update: Health Care

MT Newswires

8 months ago

AC Immune Shares Surge After Active-Immunotherapy Candidate Gets FDA Fast Track Designation for Alzheimer's Disease

AC Immune wins FDA fast track for Alzheimer’s vaccine

Pharmaceutical Technology

8 months ago

AC Immune wins FDA fast track for Alzheimer’s vaccine

AC Immune’s ACI-35.030 (now “JNJ-2056”) Granted FDA Fast Track Designation for Alzheimer’s Disease

GlobeNewswire

8 months ago

AC Immune’s ACI-35.030 (now “JNJ-2056”) Granted FDA Fast Track Designation for Alzheimer’s Disease

AC Immune Showcasing its Novel Morphomer-Antibody Drug Conjugate (morADC) Platform for the Treatment of Neurodegenerative Diseases at AAIC 2024

GlobeNewswire

8 months ago

AC Immune Showcasing its Novel Morphomer-Antibody Drug Conjugate (morADC) Platform for the Treatment of Neurodegenerative Diseases at AAIC 2024

Here's Why Shareholders May Want To Be Cautious With Increasing AC Immune SA's (NASDAQ:ACIU) CEO Pay Packet

Simply Wall St.

9 months ago

Here's Why Shareholders May Want To Be Cautious With Increasing AC Immune SA's (NASDAQ:ACIU) CEO Pay Packet

The Zacks Analyst Blog Highlights Biogen, Eli Lilly's, Prothena and AC Immune

Zacks

10 months ago

The Zacks Analyst Blog Highlights Biogen, Eli Lilly's, Prothena and AC Immune

AC Immune SA (NASDAQ:ACIU): Are Analysts Optimistic?

Simply Wall St.

10 months ago

AC Immune SA (NASDAQ:ACIU): Are Analysts Optimistic?

MT Newswires

10 months ago

--BTIG Starts AC Immune With Buy Rating, $8 Price Target

AC Immune to Present at the Jefferies Global Healthcare Conference in June 2024

GlobeNewswire

10 months ago

AC Immune to Present at the Jefferies Global Healthcare Conference in June 2024

Individual investors own 24% of AC Immune SA (NASDAQ:ACIU) shares but private equity firms control 30% of the company

Simply Wall St.

10 months ago

Individual investors own 24% of AC Immune SA (NASDAQ:ACIU) shares but private equity firms control 30% of the company

MT Newswires

a year ago

Sector Update: Health Care Stocks Mixed Late Afternoon

MT Newswires

a year ago

Sector Update: Health Care

MT Newswires

a year ago

Top Midday Gainers

Takeda shells out $100m to license AC Immune’s Phase II Alzheimer’s therapy

Pharmaceutical Technology

a year ago

Takeda shells out $100m to license AC Immune’s Phase II Alzheimer’s therapy

Takeda nabs option to license Alzheimer’s immunotherapies from AC Immune

BioPharma Dive

a year ago

Takeda nabs option to license Alzheimer’s immunotherapies from AC Immune

MT Newswires

a year ago

Top Premarket Gainers

MT Newswires

a year ago

Takeda Pharmaceutical, AC Immune Agree to Option and Licence Agreement, Including on Alzheimer's Treatment Candidate

Associated Press Finance

a year ago

AC Immune: Q1 Earnings Snapshot

AC Immune Reports First Quarter 2024 Financial Results and Provides a Corporate Update

GlobeNewswire

a year ago

AC Immune Reports First Quarter 2024 Financial Results and Provides a Corporate Update

AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer’s Disease

GlobeNewswire

a year ago

AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer’s Disease

We Think AC Immune (NASDAQ:ACIU) Can Afford To Drive Business Growth

Simply Wall St.

a year ago

We Think AC Immune (NASDAQ:ACIU) Can Afford To Drive Business Growth

Further weakness as AC Immune (NASDAQ:ACIU) drops 12% this week, taking three-year losses to 58%

Simply Wall St.

a year ago

Further weakness as AC Immune (NASDAQ:ACIU) drops 12% this week, taking three-year losses to 58%

AC Immune Reports Full Year 2023 Financial Results and Provides a Corporate Update

GlobeNewswire

a year ago

AC Immune Reports Full Year 2023 Financial Results and Provides a Corporate Update

AC Immune Announces Upcoming Presentations at AD/PD™ 2024

GlobeNewswire

a year ago

AC Immune Announces Upcoming Presentations at AD/PD™ 2024

AbbVie (ABBV) Announces Appointment of New CEO Robert Michael

Zacks

a year ago

AbbVie (ABBV) Announces Appointment of New CEO Robert Michael

GeNeuro Launches an Offering With a Commitment to Subscribe by Existing Shareholders and Announces Its Cash Position at December 31, 2023

Business Wire

a year ago

GeNeuro Launches an Offering With a Commitment to Subscribe by Existing Shareholders and Announces Its Cash Position at December 31, 2023

Down -35.7% in 4 Weeks, Here's Why AC Immune (ACIU) Looks Ripe for a Turnaround

Zacks

a year ago

Down -35.7% in 4 Weeks, Here's Why AC Immune (ACIU) Looks Ripe for a Turnaround

4 Best Breakout Stocks to Buy for Superlative Returns

Zacks

a year ago

4 Best Breakout Stocks to Buy for Superlative Returns

5 Relative Price Strength Stocks Compelling Enough to Buy

Zacks

a year ago

5 Relative Price Strength Stocks Compelling Enough to Buy

Best Value Stocks to Buy for January 29th

Zacks

a year ago

Best Value Stocks to Buy for January 29th

Univest Financial Corporation (NASDAQ:UVSP) Q4 2023 Earnings Call Transcript

Insider Monkey

a year ago

Univest Financial Corporation (NASDAQ:UVSP) Q4 2023 Earnings Call Transcript

BJ’s Restaurants, Dell, and More Stocks See Action From Activist Investors

Barrons.com

a year ago

BJ’s Restaurants, Dell, and More Stocks See Action From Activist Investors

Reuters

a year ago

UPDATE 1-Bank of America bonuses for dealmakers, traders are broadly flat -source

Bank of America bonuses for dealmakers, traders are broadly flat -source

Reuters

a year ago

Bank of America bonuses for dealmakers, traders are broadly flat -source

Esquire Financial Holdings Full Year 2023 Earnings: In Line With Expectations

Simply Wall St.

a year ago

Esquire Financial Holdings Full Year 2023 Earnings: In Line With Expectations

SUMMIT HOTEL PROPERTIES DECLARES FOURTH QUARTER 2023 DIVIDENDS

PR Newswire

a year ago

SUMMIT HOTEL PROPERTIES DECLARES FOURTH QUARTER 2023 DIVIDENDS

Amalgamated Financial Corp. Reports Fourth Quarter 2023 Financial Results: $170.8 Million Deposit Growth Excluding Brokered CDs; Net Interest Margin Rises to 3.44%

GlobeNewswire

a year ago

Amalgamated Financial Corp. Reports Fourth Quarter 2023 Financial Results: $170.8 Million Deposit Growth Excluding Brokered CDs; Net Interest Margin Rises to 3.44%

Data Analytics Stocks Q2 Teardown: Health Catalyst (NASDAQ:HCAT) Vs The Rest

StockStory

a year ago

Data Analytics Stocks Q2 Teardown: Health Catalyst (NASDAQ:HCAT) Vs The Rest

Oatly and Carvel partner to bring dairy-free flavors to stores nationwide

Food Dive

a year ago

Oatly and Carvel partner to bring dairy-free flavors to stores nationwide

PubMatic to Announce Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024

GlobeNewswire

a year ago

PubMatic to Announce Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024

AC Immune to Regain Global Rights to Crenezumab and Semorinemab

GlobeNewswire

a year ago

AC Immune to Regain Global Rights to Crenezumab and Semorinemab

Reuters

a year ago

CORRECTED-SEC probes B. Riley deals with client tied to failed hedge fund - Bloomberg News

Is Trending Stock Ardmore Shipping Corporation (ASC) a Buy Now?

Zacks

a year ago

Is Trending Stock Ardmore Shipping Corporation (ASC) a Buy Now?

AC Immune (ACIU) is a Great Momentum Stock: Should You Buy?

Zacks

a year ago

AC Immune (ACIU) is a Great Momentum Stock: Should You Buy?

Shareholders Would Not Be Objecting To Franklin Covey Co.'s (NYSE:FC) CEO Compensation And Here's Why

Simply Wall St.

a year ago

Shareholders Would Not Be Objecting To Franklin Covey Co.'s (NYSE:FC) CEO Compensation And Here's Why

Wolfe Research Initiates Coverage On Four Hotel REITs: How Do They Compare?

Benzinga

a year ago

Wolfe Research Initiates Coverage On Four Hotel REITs: How Do They Compare?

Here’s Why B Riley Financial (RILY) Fell in Q4

Insider Monkey

a year ago

Here’s Why B Riley Financial (RILY) Fell in Q4

Star Group, L.P. Declares Quarterly Distribution of 16.25 Cents per Unit

GlobeNewswire

a year ago

Star Group, L.P. Declares Quarterly Distribution of 16.25 Cents per Unit

Cogent Biosciences Announces Planned 2024 Milestones for Bezuclastinib and Emerging Portfolio of Selective and Potent Targeted Therapeutics

GlobeNewswire

a year ago

Cogent Biosciences Announces Planned 2024 Milestones for Bezuclastinib and Emerging Portfolio of Selective and Potent Targeted Therapeutics

5 Small-Cap Stocks to Play the January Effect

Zacks

a year ago

5 Small-Cap Stocks to Play the January Effect

VALNEVA - Declaration of shares and voting rights: December 31, 2023

GlobeNewswire

a year ago

VALNEVA - Declaration of shares and voting rights: December 31, 2023

HRMY or ACAD: Which Is the Better Value Stock Right Now?

Zacks

a year ago

HRMY or ACAD: Which Is the Better Value Stock Right Now?

Forget This 8.8%-Yielding Dividend Stock. Consider These Even Higher-Yielding Payouts Instead.

Motley Fool

a year ago

Forget This 8.8%-Yielding Dividend Stock. Consider These Even Higher-Yielding Payouts Instead.

AC Immune (ACIU) Upgraded to Buy: Here's Why

Zacks

a year ago

AC Immune (ACIU) Upgraded to Buy: Here's Why

AC Immune Progress Update on Phase 2 Active Immunotherapy Clinical Pipeline for Alzheimer's and Parkinson diseases

GlobeNewswire

a year ago

AC Immune Progress Update on Phase 2 Active Immunotherapy Clinical Pipeline for Alzheimer's and Parkinson diseases

Ceva Extends its Connect IP Portfolio with Wi-Fi 7 Platform for High-End Consumer and Industrial IoT

PR Newswire

a year ago

Ceva Extends its Connect IP Portfolio with Wi-Fi 7 Platform for High-End Consumer and Industrial IoT

What Does Matthews International Corporation's (NASDAQ:MATW) Share Price Indicate?

Simply Wall St.

a year ago

What Does Matthews International Corporation's (NASDAQ:MATW) Share Price Indicate?

Portfolio Powerhouses: 3 Stocks That Could Make You a Millionaire by 2026

InvestorPlace

a year ago

Portfolio Powerhouses: 3 Stocks That Could Make You a Millionaire by 2026

At US$24.48, Is Legacy Housing Corporation (NASDAQ:LEGH) Worth Looking At Closely?

Simply Wall St.

a year ago

At US$24.48, Is Legacy Housing Corporation (NASDAQ:LEGH) Worth Looking At Closely?

Fate Therapeutics (FATE) Upgraded to Buy: Here's Why

Zacks

a year ago

Fate Therapeutics (FATE) Upgraded to Buy: Here's Why

New Strong Sell Stocks for December 22nd

Zacks

a year ago

New Strong Sell Stocks for December 22nd

Better Awards Hardworking Family with Home Giveaway and Launches HOPE Grant to Bolster Home Accessibility

Business Wire

a year ago

Better Awards Hardworking Family with Home Giveaway and Launches HOPE Grant to Bolster Home Accessibility

Evolus Enters into Licensing Agreement with Symatese to Exclusively Distribute Next-Generation Dermal Fillers in Europe

Business Wire

a year ago

Evolus Enters into Licensing Agreement with Symatese to Exclusively Distribute Next-Generation Dermal Fillers in Europe

Share on Social Networks: